ASCEND
BY NTHRYS

NTHRYSInternshipsAi Drug Repurposing

AI Drug Repurposing for Rare Disease Research

Ai Drug Repurposing
AI Drug Repurposing for Rare Disease Research
Focused area
Variant
Pay · Join
Step 3 of 5Choose focused area
Field
Category
Focused area
You might prefer
AI Knowledge Graph Drug Repurposing ResearchMachine Learning Omics-Driven Repurposing StudiesDeep Learning for Drug Side Effect RepurposingAI Literature Mining for Repurposing SignalsAI Polypharmacology-Based Repurposing ResearchAI Patient Data-Driven Drug Repurposing ResearchAI Pandemic Drug Repurposing Response ResearchAI Network Medicine Drug Repurposing ResearchAI Combination Therapy Repurposing StudiesAI Molecular Docking Drug RepurposingGraph Neural Networks Drug Target PredictionTransformer Models Biomedical Text MiningAI Cancer Drug Repurposing PipelineFederated Learning Drug Discovery NetworksSMILES-Based Drug Representation LearningAI Antimicrobial Resistance Drug RepurposingClinical Trial Data Mining RepurposingAI Neurodegenerative Disease RepurposingReinforcement Learning Drug OptimizationProtein Structure AI Drug RepurposingAI Cardiovascular Drug Repurposing ResearchChemical Similarity Network Drug DiscoveryMulti-Task Learning Disease PredictionAI Inflammatory Disease Drug RepurposingSequence-Based Protein Target DiscoveryMetabolomics Data Integration Drug RepurposingAI Infectious Disease Drug RepurposingTransfer Learning Drug Response PredictionAI Autoimmune Disease Drug RepurposingGene Expression Drug Response ModelingAI Metabolic Disease Drug RepurposingAttention Mechanisms Drug Target RankingAI Pulmonary Disease Drug RepurposingPharmacophore Matching AI Drug DiscoveryAI Renal Disease Drug RepurposingSynthetic Data Generation Drug TrainingAI Gastrointestinal Disease Drug RepurposingCausal Inference Drug Effect AttributionAI Ophthalmologic Drug RepurposingTemporal Disease Progression Drug ModelingAI Dermatological Drug Repurposing ResearchCross-Species Drug Efficacy TranslationAI Orthopedic Disease Drug RepurposingExplainable AI Drug Repurposing ModelsAI Endocrine Disease Drug RepurposingZero-Shot Learning Drug RepurposingAI Psychiatric Drug Repurposing StudiesVariational Autoencoder Drug DiscoveryAI Biomarker Discovery Drug Repurposing

AI Drug Repurposing for Rare Disease Research

Internship matching approved drugs to rare diseases with AI that weighs mechanism against scarce evidence. Hands-on work runs alongside theory modules.

The focused areas below are internship topics in varied working formats. Pick one, then choose your internship type, mode… Read more

🎓 TYPE
🌐 MODE
📚 Academic: Thesis & PPT assistance included🧪 Tech: Master the protocols hands-on📝 Research > 3 months: Publication co-authorship in a Scopus-indexed journal
🔍

Showing 110 of 10

Machine Learning Prediction of Off-Target Drug Efficacy
Research investigates how deep learning models can predict secondary pharmacological effects of existing drugs against rare genetic disorders. This work generates novel therapeutic hypotheses by identifying unexpected drug-disease interactions that bypass traditional screening methods.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £815
R · £1,185
3 Months
A · £1,071
T · £1,309
R · £1,904
6 Months
A · £2,380
T · £2,909
R · £4,231
14 more durationsView Titles →
Graph Neural Networks for Protein-Drug Interaction Mapping
Studies apply graph neural networks to model complex protein interaction networks and predict drug binding affinities for rare disease targets. These computational approaches reveal hidden therapeutic pathways by analyzing structural and functional relationships in biological systems.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £738
R · £1,073
3 Months
A · £970
T · £1,185
R · £1,724
6 Months
A · £2,155
T · £2,634
R · £3,830
14 more durationsView Titles →
Federated Learning for Rare Disease Patient Data Integration
Research develops privacy-preserving federated learning frameworks to aggregate fragmented rare disease datasets across multiple medical institutions without centralizing sensitive patient information. This methodology produces robust AI models trained on previously inaccessible real-world evidence for drug repurposing applications.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £793
R · £1,154
3 Months
A · £1,043
T · £1,275
R · £1,854
6 Months
A · £2,317
T · £2,832
R · £4,119
14 more durationsView Titles →
Transformer Models for Biomedical Literature Mining in Rare Diseases
Investigates advanced natural language processing transformers to extract drug-disease relationships and mechanistic insights from millions of published rare disease research papers. The approach uncovers clinically relevant drug repurposing candidates by systematically analyzing unstructured scientific literature.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £769
R · £1,118
3 Months
A · £1,011
T · £1,235
R · £1,796
6 Months
A · £2,245
T · £2,744
R · £3,991
14 more durationsView Titles →
Metabolomic Pathway Analysis Using Interpretable AI Systems
Studies employ explainable AI techniques to map how repurposed drugs alter metabolic pathways specific to rare monogenic disorders. This research produces mechanistic understanding of drug action by connecting AI predictions to validated biochemical outcomes.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £741
R · £1,077
3 Months
A · £974
T · £1,190
R · £1,731
6 Months
A · £2,164
T · £2,645
R · £3,846
14 more durationsView Titles →
Phenotype-Genotype Association Networks for Drug Discovery
Research constructs knowledge graphs linking rare disease phenotypes, genetic variants, and drug bioactivities using machine learning-enhanced network analysis. These frameworks generate therapeutic candidates by identifying drugs that functionally complement defective genetic pathways.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £747
R · £1,086
3 Months
A · £982
T · £1,200
R · £1,746
6 Months
A · £2,182
T · £2,667
R · £3,879
14 more durationsView Titles →
Synthetic Data Generation for Rare Disease Clinical Trial Optimization
Develops generative AI models to create synthetic patient cohorts representing underrepresented rare diseases for computational clinical trial design. This approach produces evidence-based drug repurposing candidates with optimized dosing and patient stratification strategies.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £716
R · £1,041
3 Months
A · £942
T · £1,151
R · £1,673
6 Months
A · £2,092
T · £2,556
R · £3,718
14 more durationsView Titles →
Multi-Modal Foundation Models for Rare Disease Drug Screening
Investigates large-scale foundation models trained on integrated genomic, proteomic, and phenotypic data to predict drug efficacy in rare diseases. Research generates novel biomarkers and drug response predictions by leveraging cross-modal AI understanding.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £778
R · £1,131
3 Months
A · £1,023
T · £1,250
R · £1,818
6 Months
A · £2,272
T · £2,777
R · £4,039
14 more durationsView Titles →
Reinforcement Learning for Adaptive Drug Combination Strategies
Studies apply reinforcement learning to identify optimal drug combinations and treatment sequences for rare multi-factorial diseases using simulated patient response data. This computational approach discovers synergistic drug repurposing solutions not identifiable through traditional combinatorial screening.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £732
R · £1,064
3 Months
A · £962
T · £1,175
R · £1,710
6 Months
A · £2,137
T · £2,612
R · £3,798
14 more durationsView Titles →
Causal Inference Models for Drug Mechanism Validation in Rare Conditions
Research develops causal AI frameworks to distinguish genuine therapeutic mechanisms from correlative associations in rare disease drug repurposing studies. These models produce mechanistically validated drug candidates with higher clinical translation potential.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £762
R · £1,109
3 Months
A · £1,002
T · £1,225
R · £1,782
6 Months
A · £2,227
T · £2,722
R · £3,959
14 more durationsView Titles →